Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.2M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
8.53M
-
Shares change
-
+7.78M
-
Total reported value, excl. options
-
$335M
-
Value change
-
+$310M
-
Put/Call ratio
-
0.92
-
Number of buys
-
65
-
Number of sells
-
-8
-
Price
-
$39.24
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q1 2024
91 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.53M shares
of 12.2M outstanding shares and own 70.07% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (2.03M shares), Point72 Asset Management, L.P. (702K shares), Ikarian Capital, LLC (559K shares), VANGUARD GROUP INC (437K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (415K shares), Octagon Capital Advisors LP (405K shares), CITADEL ADVISORS LLC (369K shares), JANUS HENDERSON GROUP PLC (339K shares), MILLENNIUM MANAGEMENT LLC (325K shares), and Assenagon Asset Management S.A. (259K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.